Purchases and Sales Made in Q4 2024 in An2 Therapeutics, Inc. (ANTX)
This table provides information about the institutional ownership of An2 Therapeutics, Inc. (ANTX) during Q4 2024. The information is specifically focused on institutions that hold shares of AN2 Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2025
Q4 2024
|
Almitas Capital LLC
Santa Monica, CA |
BUY
|
- |
1.31MNew |
$1.31M - $2.19M
|
1.31M
$1.48M
|
|
|
Jan 29, 2025
Q4 2024
|
Peapod Lane Capital LLC
Bedford Hills, NY |
BUY
|
- |
579KNew |
$579K - $967K
|
579K
$654K
|
|
|
Feb 13, 2025
Q4 2024
|
Bank Of Montreal
Toronto, A6 |
BUY
|
- |
422KNew |
$422K - $705K
|
422K
$477K
|
|
|
Feb 14, 2025
Q4 2024
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
BUY
|
- |
407K+ 336.97% |
$407K - $680K
|
528K
$597K
|
|
|
Feb 13, 2025
Q4 2024
|
Bank Of Nova Scotia
|
BUY
|
- |
395KNew |
$395K - $659K
|
395K
$446K
|
|
|
Feb 14, 2025
Q4 2024
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
369K+ 2278.01% |
$369K - $617K
|
385K
$436K
|
|
|
Feb 12, 2025
Q4 2024
|
Aldebaran Capital, LLC
Indianapolis, IN |
BUY
|
- |
243K+ 241.97% |
$243K - $406K
|
344K
$388K
|
|
|
Feb 14, 2025
Q4 2024
|
Two Sigma Investments, LP
New York, NY |
BUY
|
- |
222K+ 125.11% |
$222K - $372K
|
400K
$452K
|
|
|
Feb 13, 2025
Q4 2024
|
Stonepine Capital Management, LLC
Bend, OR |
BUY
|
- |
197KNew |
$197K - $329K
|
197K
$222K
|
|
|
Feb 14, 2025
Q4 2024
|
Ubs Group Ag
|
BUY
|
- |
170KNew |
$170K - $284K
|
170K
$192K
|
|
|
Feb 13, 2025
Q4 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
156K+ 36.8% |
$156K - $260K
|
580K
$655K
|
|
|
Feb 14, 2025
Q4 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
68KNew |
$68K - $114K
|
68K
$76.8K
|
|
|
Feb 14, 2025
Q4 2024
|
Squarepoint Ops LLC
New York, NY |
BUY
|
- |
62.4KNew |
$62.4K - $104K
|
62.4K
$70.6K
|
|
|
Feb 14, 2025
Q4 2024
|
State Street Corp
Boston, MA |
BUY
|
- |
26.7K+ 44.28% |
$26.7K - $44.6K
|
87K
$98.3K
|
|
|
Jan 14, 2025
Q4 2024
|
Marquette Asset Management, LLC
|
BUY
|
- |
18.7K+ 29.0% |
$18.7K - $31.2K
|
83.2K
$94K
|
|
|
Feb 14, 2025
Q4 2024
|
Northern Trust Corp
Chicago, IL |
BUY
|
- |
10.6K+ 32.52% |
$10.6K - $17.7K
|
43.2K
$48.8K
|
|
|
Feb 13, 2025
Q4 2024
|
Xtx Topco LTD
London, X0 |
BUY
|
- |
10.5K+ 44.47% |
$10.5K - $17.6K
|
34.2K
$38.6K
|
|
|
Feb 14, 2025
Q4 2024
|
Qube Research & Technologies LTD
London, X0 |
BUY
|
- |
10.2KNew |
$10.2K - $17K
|
10.2K
$11.5K
|
|
|
Feb 12, 2025
Q4 2024
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
7.63K+ 3.47% |
$7.63K - $12.7K
|
228K
$257K
|
|
|
Feb 13, 2025
Q4 2024
|
Federated Hermes, Inc.
Pittsburgh, PA |
BUY
|
- |
4.49K+ 149.23% |
$4.49K - $7.49K
|
7.49K
$8.47K
|
|
|
Feb 05, 2025
Q4 2024
|
Sbi Securities Co., Ltd.
Tokyo, M0 |
BUY
|
- |
200New |
$200 - $334
|
200
$226
|
|
|
Feb 13, 2025
Q4 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Feb 12, 2025
Q4 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-2- 3.7% |
$2 - $3.34
|
52
$58.8
|
|
|
Feb 14, 2025
Q4 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-3- 0.99% |
$3 - $5.01
|
300
$339
|
|
|
Feb 13, 2025
Q4 2024
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-2.79K- 65.63% |
$2.79K - $4.66K
|
1.46K
$1.65K
|
|
|
Feb 11, 2025
Q4 2024
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-5.58K- 0.54% |
$5.58K - $9.32K
|
1.04M
$1.17M
|
|
|
Feb 14, 2025
Q4 2024
|
Bridgeway Capital Management, LLC
Houston, TX |
SELL
|
- |
-34.8K- 17.66% |
$34.8K - $58.1K
|
162K
$183K
|
|
|
Feb 14, 2025
Q4 2024
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-39.2K- 59.3% |
$39.2K - $65.5K
|
26.9K
$30.4K
|
|
|
Feb 14, 2025
Q4 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-189K- 47.39% |
$189K - $315K
|
209K
$237K
|